Leading Global Pharmaceutical Company in India
Ведущая мировая фармацевтическая компания в Индии | Антиретровирусные препараты
Hetero , первая компания в Индии, запустившая в Индии генерическую версию инъекционного препарата Ремдесивир, COVIFOR, который используется для лечения случаев госпитализации с COVID-19. Нажмите здесь, чтобы узнать больше.
- Type
- distributor (our classification of the record, not a statement by the company)
- Role
- Distributor
- Location
- Netherlands
- Website
- https://hetero.com
- Categories
- Фармацевтическое производство
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- domain-registered (green), checked 2026-08-08 Domain registry record
- debarment-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- sanctions-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)